SCHEMBL18883149

SCHEMBL18883149

[1H]SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL887442 0.50
SCHEMBL5640 0.47
SCHEMBL15869348 0.47
SCHEMBL10417889 0.47
Iodide SCHEMBL377678 0.41
Ammonia Solution, Strong SCHEMBL4138673 0.41
SCHEMBL5859282 0.41
SCHEMBL5383540 0.41
SCHEMBL10275116 0.41
Hydrogen Sulfide SCHEMBL5192038 0.41

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170145058-A1 METHOD FOR TARGETED CONJUGATION OF PEPTIDES AND PROTEINS BY PAIRED C2 BRIDGING OF CYSTEINE AMINO ACIDS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-05-25 US disclosed
US-20140065153-A1 Methods for Treating Hair Loss Disorders THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-03-06 US disclosed
US-8653286-B2 Intermediates useful in the preparation of maleimide functionalized polymers NEKTAR THERAPEUTICS (US) 2014-02-18 US disclosed
US-8653131-B2 Polymeric benzyl carbonate-derivatives BAXTER HEALTHCARE S.A. (CH) 2014-02-18 US disclosed
US-20140045770-A1 OLIGOMER-PROTEASE INHIBITOR CONJUGATES NEKTAR THERAPEUTICS (US) 2014-02-13 US disclosed
US-20140039205-A1 Method for Preparing Branched Functionalized Polymers Using Branched Polyol Cores NEKTAR THERAPEUTICS (US) 2014-02-06 US disclosed
US-20140017198-A1 INHIBITORS OF HEPATITIS C VIRUS GILEAD PHARMASSET LLC 2014-01-16 US disclosed
US-20130303531-A1 TETRA-SUBSTITUTED NDGA DERIVATIVES VIA ETHER BONDS AND CARBAMATE BONDS AND THEIR SYNTHESIS AND PHARMACEUTICAL USE CHEN QINGQI (US) 2013-11-14 US disclosed
US-8568705-B2 Method for preparing branched functionalized polymers using branched polyol cores NEKTAR THERAPEUTICS (US) 2013-10-29 US disclosed
US-20130280700-A1 FOUR-COLOR DNA SEQUENCING BY SYNTHESIS USING CLEAVABLE FLUORESCENT NUCLEOTIDE REVERSIBLE TERMINATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2013-10-24 US disclosed
US-20080064851-A1 Active carbonate esters of water-soluble polyoxyethylene glycol NEKTAR THERAPEUTICS 2008-03-13 US disclosed
US-20080039656-A1 Synthesis and Application of Procainamide Analogs for Use in an Immunoassay DADE BEHRING INC. (US) 2008-02-14 US disclosed
US-20070299073-A1 Imidazolyl derivatives IPSEN PHARMA S.A.S. (FR) 2007-12-27 US disclosed
US-7279340-B2 Synthesis and application of procainamide analogs for use in an immunoassay DADE BEHRING INC. (US) 2007-10-09 US disclosed
US-7238695-B2 Imidazolyl derivatives SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, SAS (FR) 2007-07-03 US disclosed
US-20070117102-A1 Nucleotide analogs FLUIDIGM CORPORATION 2007-05-24 US disclosed
US-7217575-B2 Avidin derivatives and uses thereof YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2007-05-15 US disclosed
US-20070032653-A1 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) 2007-02-08 US disclosed
US-20070031371-A1 Method for Preparing Branched Functionalized Polymers Using Branched Polyol Cores NEKTAR THERAPEUTICS AL, CORPORATION 2007-02-08 US disclosed
US-7160887-B1 Aromatic amine derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-09 US disclosed